NF-κB antiapoptosis:: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

被引:2460
|
作者
Wang, CY [1 ]
Mayo, MW
Korneluk, RG
Goeddel, DV
Baldwin, AS
机构
[1] Univ N Carolina, Sch Dent, Lineberger Comprehens Canc Ctr, Dept Endodont, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA
[3] Childrens Hosp Eastern Ontario, Mol Genet Res Lab, Ottawa, ON K1H 8M5, Canada
[4] Tularik, S San Francisco, CA 94080 USA
[5] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1126/science.281.5383.1680
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumor necrosis factor alpha (TNF-alpha) binding to the TNF receptor (TNFR) potentially initiates apoptosis and activates the transcription factor nuclear factor kappa B (NF-kappa B), which suppresses apoptosis by an unknown mechanism. The activation of NF-kappa B was found to block the activation of caspase-8. TRAF1 (TNFR-associated factor 1), TRAF2, and the inhibitor-of-apoptosis (IAP) proteins c-IAP1 and c-IAP2 were identified as gene targets of NF-kappa B transcriptional activity. in cells in which NF-kappa B was inactive, all of these proteins were required to fully suppress TNF-induced apoptosis, whereas c-IAP1 and c-IAP2 were sufficient to suppress etoposide-induced apoptosis. Thus, NF-kappa B activates a group of gene products that function cooperatively at the earliest checkpoint to suppress TNF-alpha-mediated apoptosis and that function more distally to suppress genotoxic agent-mediated apoptosis.
引用
收藏
页码:1680 / 1683
页数:4
相关论文
共 50 条
  • [11] Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo
    Conze, DB
    Albert, L
    Ferrick, DA
    Goeddel, DV
    Yeh, WC
    Mak, T
    Ashwell, JD
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (08) : 3348 - 3356
  • [12] Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies
    de Graaf, AO
    van Krieken, JH
    Tönnissen, E
    Wissink, W
    van de Locht, L
    Overes, I
    Dolstra, H
    de Witte, T
    van der Reijden, BA
    Jansen, JH
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (06) : 852 - 859
  • [13] Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: Relationships with clinicopathological features and prognosis
    Ponnelle, T
    Chapusot, C
    Martin, L
    Bonithon-Kopp, C
    Bouvier, AM
    Plenchette, S
    Rageot, D
    Faivre, J
    Solary, E
    Piard, F
    PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (11) : 723 - 731
  • [14] Effect of electroacupuncture on c-IAP1 mRNA and c-IAP2 mRNA in synovial tissues of rats with adjuvant arthritis
    Ai Kun
    Li Yan-ling
    Qi Fang
    Liu Li
    Chang Xiao-rong
    Yu Zhao-an
    JOURNAL OF ACUPUNCTURE AND TUINA SCIENCE, 2019, 17 (01) : 16 - 23
  • [15] Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro
    Park, SM
    Yoon, JB
    Lee, TH
    FEBS LETTERS, 2004, 566 (1-3): : 151 - 156
  • [16] Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells
    Yang, QH
    Du, CY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) : 16963 - 16970
  • [17] Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment
    Schwarzenbach, Christian
    Tatsch, Larissa
    Vilar, Juliana Brandstetter
    Rasenberger, Birgit
    Beltzig, Lea
    Kaina, Bernd
    Tomicic, Maja T.
    Christmann, Markus
    CANCERS, 2021, 13 (14)
  • [18] The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex
    Shu, HB
    Takeuchi, M
    Goeddel, DV
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 13973 - 13978
  • [19] Targeting c-IAP1, c-IAP2, and Bcl-2 eliminates senescent glioblastoma cells following temozolomide treatment
    Schwarzenbach, Christian
    Tatsch, Larissa
    Vilar, Juliana Brandstetter
    Rasenberger, Birgit
    Beltzig, Lea
    Kaina, Bernd
    Tomicic, Maja
    Christmann, Markus
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 49 - 49
  • [20] TRAF1 is a TNF inducible regulator of NF-κB activation
    Carpentier, I
    Beyaert, R
    FEBS LETTERS, 1999, 460 (02) : 246 - 250